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Pulmonary metastatic melanoma
To the Editor:
I read with interest the article by Rebecca
and colleagues.1 I want to commend the
authors for their great effort to produce this
important article, but I have some com-
ments about it.
The type of extrathoracic metastasis can
affect the prognosis, but you did not men-
tion which type of extrathoracic metastasis
was present. The number of these extratho-
racic metastasis also was not mentioned. I
think that these extrathoracic metastases,
even with their control, are a contraindica-
tion for further surgical intervention.
The frequency of the site of these pul-
monary metastasis was also not mentioned.
From your results there were 23 bilateral
thoracotomies: were they done at the same
sitting or in sequence? Why did you not
perform median sternotomy for bilateral
management of these metastasis?
I want also to ask about the side of
pulmonary metastasis and its effect for the
prognosis.
From the results, you had mentioned
that the median follow-up of living patients
was 65 months (0.1–524 months).1 From
that result I can suggest that the least time
for follow-up was 0.1 month, which equals
only 3 days. That is too little for follow-up.
Also, the maximum follow-up was 524
months, which equals 43.6 years. That ex-
ceeds the proposed time of the study (from
January 1, 1970, to June 1, 2004, which is
only about 34.5 years).
My last comment concerns the last
word of your article: It reads Figure E3; I
think that you meant Figure 1.
Mohamed Fouad Ismail, MD
Cardiothoracic Surgery Department
Mansoura University Hospitals
Mansoura, Egypt
[Response declined]
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Superior vena cava resection
without blood flow interruption
To the Editor:
We agree with Leo and associates1 that
clamping of the superior vena cava (SVC)
can cause severe hemodynamic changes
with possible serious clinical conse-
quences, particularly when the SVC blood
flow was not already gradually reduced by
venous wall pathology, usually neoplastic
infiltration. For this reason, at the begin-
ning of our clinical experience with SVC
resections, we successfully used a tempo-
rary intraluminal shunt.2
However, after a few cases, we shifted
to the much more simple and accurate tech-
nique of performing, as the first procedure
after sternotomy (or thoracotomy), ringed
polytetrafluoroethylene graft (12–18 mm)
interposition between the amputated right
atrial appendage tip and the left (occasion-
ally right on thoracotomy cases) brachioce-
phalic trunk (Figure 1). This procedure
does not interrupt blood flow through the
SVC (Figure 1, A), and after the blood flow
through this conduit is established, SVC
clamping (Figure 1, B) and removal (Fig-
Figure 1. In all phases of the procedure, upper body district venous discharge is maintained through one of the
brachiocephalic trunks.
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